The anti-viral effects of OX-40 agonistic mAbs has been studied in patients affected with chronic hepatitis B where OX-40 is crucial to suppress HBV replication, by stimulating the activity of CD8+ T cells (13). This evidence concerns the gene TNFRSF4 and chronic hepatitis B virus infection.